Bernard Siegel

Bernard Siegel is a Florida-based attorney and prominent advocate in the regenerative medicine and stem cell research fields. A graduate of the University of Miami with both undergraduate and law degrees, he has been a member of the Florida Bar since 1975. After spending 30 years in courtroom practice, Siegel transitioned his career to focus on advancing stem cell research and regenerative medicine.

He is the Executive Director of the nonprofit Regenerative Medicine Foundation (formerly known as the Genetics Policy Institute) and founder of the Healthspan Action Coalition. As a cancer survivor himself, Siegel has become a recognized policy expert and patient advocate, working to bridge gaps between scientists, clinicians, industry leaders, investors, and philanthropists to accelerate the development of regenerative medicine treatments. Siegel is best known for his pivotal role in the stem cell research advocacy movement.

In 2002, he filed a landmark court case seeking a guardian for the world's first alleged human clone, which brought international attention to cloning and stem cell research issues. He played a crucial role in protecting nuclear transfer research at the United Nations in 2003 and 2004, preventing a world treaty that would have banned this vital research. His work has been profiled in multiple books on stem cell research, and he is widely credited as an "unsung hero" in advancing the field.

Through his organizations, Siegel has created a global network of stakeholders and fostered unprecedented collaboration across the regenerative medicine ecosystem.